GlassScriptPhysician profile
William F Oppat
NPI 1902873086
$8,395.56
in general payments reported to CMS, 2019-2025
26 companies · $1,888 in 2025
The $1,888 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,124 · 2020: $175 · 2021: $1,028 · 2022: $396 · 2023: $602 · 2024: $1,183 · 2025: $1,888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,720 · Travel and Lodging: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,720.46 |
| Travel and Lodging | $952.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $1,881.92 | 2019 | |
| Endologix LLC | $1,764.21 | 2021-2025 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| W. L. Gore & Associates, INC. | $1,693.84 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin, Gore Viabahn Vbx Balloon Expandable Endo |
| Inari Medical, INC. | $1,197.11 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic USA, INC. | $918.45 | 2019 | |
| Abbott Laboratories | $142.77 | 2021-2024 | Supera |
| Bard Peripheral Vascular, INC. | $98.24 | 2019 | |
| Angiodynamics, INC. | $90.72 | 2020 | |
| Stryker Corporation | $80.25 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lemaitre Vascular, INC. | $77.59 | 2024 | Restoreflow |
| Boston Scientific Corporation | $54.26 | 2021-2023 | |
| Conmed Corporation | $48.94 | 2019 | |
| Cook Medical LLC | $40.38 | 2022-2024 | Cook, Zenith |
| Penumbra, INC. | $40.36 | 2020-2021 | |
| Cordis US Corp. | $39.10 | 2025 | Mynx Control |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $36.71 | 2020 | |
| Getinge USA Sales, LLC | $28.13 | 2021 | |
| Veryan Medical Incorporated | $26.06 | 2021 | |
| Convatec INC. | $24.96 | 2023 | |
| My01 INC. | $24.60 | 2022 | |
| Silk Road Medical, INC. | $22.27 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Acera Surgical, INC. | $22.10 | 2025 | Restrata Wound Matrix |
| Cashflow Solutions, LLC | $14.40 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.72 | 2022 | |
| Artivion, INC. | $9.06 | 2019 | |
| Bolton Medical INC | $7.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Oppat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.